Introduction

Fulminant type 1 diabetes, for which the period between the advent of symptoms and the onset is very short, is a form of diabetes that occurs as a result of the rapid and complete breakdown of pancreatic β cells (1, 2). Because endogenous insulin secretion is depleted starting from early onset, uneven blood glucose levels and serious low glucose levels are often observed in fulminant type 1 diabetes patients, and it is predicted to have clinical conditions resembling those of brittle diabetes (3), which is reported to have a high risk of the onset of microangiopathy. The Fulminant Type 1 Diabetes Research and Study Committee reported that fulminant type 1 diabetes patients are among those of the high-risk group, where microangiopathy complications tend to occur and develop (4).
We have reported that the mortality and incidence of endstage renal disease in patients with type 1 diabetes in our diabetes center were significantly lower than those in general hospitals (5 
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Results
The clinical conditions five years after the onset of diabetes
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The clinical conditions ten years after the onset of diabetes
The conditions ten years after the onset of diabetes are shown in (Table 3) .
Characteristics of the fulminant type 1 diabetes patients
The clinical data for the 16 subjects of the FT1DM group are shown in Table 4 . The disease duration shows the number of years during which clinical follow-ups were conducted. Two cases of retinopathy were observed during the full observation period, both of which were diagnosed ten years after the onset of diabetes. Two cases of nephropathy were observed, which were diagnosed 9.8 and 10.4 years after the onset of diabetes. T a b l e 3 . Ch a r a c t e r i s t i c s o f t h e F u l mi n a n t a n d No n -f u l mi n a n t T y p e 1 T a b l e 4 . Ch a r a c t e r i s t i c s o f t h e F u l mi n a n t T y p e 1 Di a b e t e s P a t i e n t s sex retinopathy F   47  33  49  47  49  42  38  35  22  49  38  64  25  27  30  37 intensive blood glucose control can prevent the development of microangiopathy complications in type 1 diabetes (7) . It goes without saying that blood pressure control (8, 9) 
Conclusion
No difference in the development of microangiopathy complications was observed between the patients visiting the center with fulminant type 1 diabetes and those with nonfulminant type 1 diabetes. The Diabetes Control and Complications Trial Research Group (DCCT) USA clarified that
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